Suppr超能文献

HEART 途径加速诊断方案实施:前瞻性前后中断时间序列设计与方法

HEART Pathway Accelerated Diagnostic Protocol Implementation: Prospective Pre-Post Interrupted Time Series Design and Methods.

作者信息

Mahler Simon A, Burke Gregory L, Duncan Pamela W, Case Larry D, Herrington David M, Riley Robert F, Wells Brian J, Hiestand Brian C, Miller Chadwick D

机构信息

Wake Forest School of Medicine, Department of Emergency Medicine, Winston Salem, NC, United States.

出版信息

JMIR Res Protoc. 2016 Jan 22;5(1):e10. doi: 10.2196/resprot.4802.

Abstract

BACKGROUND

Most patients presenting to US Emergency Departments (ED) with chest pain are hospitalized for comprehensive testing. These evaluations cost the US health system >$10 billion annually, but have a diagnostic yield for acute coronary syndrome (ACS) of <10%. The history/ECG/age/risk factors/troponin (HEART) Pathway is an accelerated diagnostic protocol (ADP), designed to improve care for patients with acute chest pain by identifying patients for early ED discharge. Prior efficacy studies demonstrate that the HEART Pathway safely reduces cardiac testing, while maintaining an acceptably low adverse event rate.

OBJECTIVE

The purpose of this study is to determine the effectiveness of HEART Pathway ADP implementation within a health system.

METHODS

This controlled before-after study will accrue adult patients with acute chest pain, but without ST-segment elevation myocardial infarction on electrocardiogram for two years and is expected to include approximately 10,000 patients. Outcomes measures include hospitalization rate, objective cardiac testing rates (stress testing and angiography), length of stay, and rates of recurrent cardiac care for participants.

RESULTS

In pilot data, the HEART Pathway decreased hospitalizations by 21%, decreased hospital length (median of 12 hour reduction), without increasing adverse events or recurrent care. At the writing of this paper, data has been collected on >5000 patient encounters. The HEART Pathway has been fully integrated into health system electronic medical records, providing real-time decision support to our providers.

CONCLUSIONS

We hypothesize that the HEART Pathway will safely reduce healthcare utilization. This study could provide a model for delivering high-value care to the 8-10 million US ED patients with acute chest pain each year.

CLINICALTRIAL

Clinicaltrials.gov NCT02056964; https://clinicaltrials.gov/ct2/show/NCT02056964 (Archived by WebCite at http://www.webcitation.org/6ccajsgyu).

摘要

背景

大多数因胸痛前往美国急诊科(ED)就诊的患者会住院接受全面检查。这些评估每年使美国医疗系统花费超过100亿美元,但急性冠状动脉综合征(ACS)的诊断率低于10%。病史/心电图/年龄/危险因素/肌钙蛋白(HEART)路径是一种加速诊断方案(ADP),旨在通过识别可早期出院的患者来改善对急性胸痛患者的治疗。先前的疗效研究表明,HEART路径可安全减少心脏检查,同时保持可接受的低不良事件发生率。

目的

本研究的目的是确定在一个医疗系统内实施HEART路径ADP的有效性。

方法

这项前后对照研究将纳入成年急性胸痛患者,但心电图无ST段抬高型心肌梗死,为期两年,预计纳入约10000名患者。结局指标包括住院率、客观心脏检查率(负荷试验和血管造影)、住院时间以及参与者再次接受心脏治疗的比率。

结果

在试点数据中,HEART路径使住院率降低了21%,缩短了住院时间(中位数减少12小时),且未增加不良事件或再次治疗的比率。在撰写本文时,已收集了超过5000例患者就诊的数据。HEART路径已完全整合到医疗系统电子病历中,为我们的医护人员提供实时决策支持。

结论

我们假设HEART路径将安全降低医疗资源的利用。本研究可为每年为800 - 1000万美国急诊科急性胸痛患者提供高价值医疗服务提供一个模式。

临床试验

Clinicaltrials.gov NCT02056964;https://clinicaltrials.gov/ct2/show/NCT02056964(由WebCite存档于http://www.webcitation.org/6ccajsgyu)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f9/4744329/3c1caae93477/resprot_v5i1e10_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验